Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 21, 2004 07:00 ET | Source: eLocity Inc.

eLocity Inc.: Stocks to Watch for September 21: DEZ, WLSF, EYET

SARASOTA, Fla., Sept. 21, 2004 (PRIMEZONE) -- The following is an investment opinion issued by eLocity Inc.: Desert Sun Mining Corp. (TSX Venture Exchange:DSM) (AMEX:DEZ), Eyetech Pharmaceuticals...
September 08, 2004 02:10 ET | Source: Crucell N.V.

Crucell and DSM Announce PER.C6 Licensing Agreement with MorphoSys for Antibody Production

LEIDEN and SITTARD, The Netherlands, Sept. 8, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today...
July 12, 2004 09:44 ET | Source: MLON International Ventures, Inc.

Mellon Research, Inc. and Their Group of International Financiers

SCOTTSDALE, Ariz., July 12, 2004 (PRIMEZONE) -- Mellon Research (Pink Sheets:MLON) is an established "boutique investment banking" firm that helps private companies raise capital via a public...
June 24, 2004 07:00 ET | Source: Human BioSystems

Richard Wells, Ph.D. Appointed to Human BioSystems Advisory Board

PALO ALTO, Calif., June 24, 2004 (PRIMEZONE) -- Harry Masuda, President and CEO of Human BioSystems (OTCBB:HBSC), a biomedical company engaged in research and development of new technologies to...
February 24, 2004 02:38 ET | Source: Xenova Group PLC

Xenova Group plc -- Preliminary Results for the Year Ended 31 December 2003

SLOUGH, U.K., Feb. 24, 2004 (PRIMEZONE) -- Xenova Group plc (Nasdaq:XNVA) (LSE:XEN) today announced its results for the year ended 31 December 2003. Highlights: -- Acquisition of KS Biomedix...
January 13, 2004 02:15 ET | Source: Crucell N.V.

Crucell Grants Pfizer an Exclusive License on West Nile Virus Vaccine for Horses

LEIDEN, The Netherlands, Jan. 13, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL), (Nasdaq:CRXL) announced today that it has granted U.S.-based Pfizer Inc. (NYSE:PFE) an...
June 18, 2003 10:37 ET | Source: Pfizer AB

Pfizer sees Strong Prospects Based on Rapid Integration of Pharmacia and Expanded Product and R&D Opportunities

STOCKHOLM, Sweden and NEW YORK, June 18, 2003 (PRIMEZONE) -- Pfizer (NYSE:PFE): - Estimates 16 Percent Compounded Annual Growth in Adjusted Diluted EPS* Between 2002-2004; Pharmacia Acquisition To...
August 27, 2002 10:32 ET | Source: Vertex Interactive, Inc.

Vertex Interactive Selected for Deloitte & Touche `Fast 50' Program

PARAMUS, N.J., Aug. 27, 2002 (PRIMEZONE) -- Vertex Interactive, Inc. (OTCBB:VETX), a leading provider of supply chain execution and order fulfillment technologies, today announced that it has been...